today announced that IceCure's ICE3 trial and five additional studies featuring new data on ProSense's® use in breast cancer and fibroadenoma were presented at the 2024 European Society of Breast ...

As Breast Cancer Awareness Month continues, we are reminded of the resilience and strength of those affected by this disease.

Use precise geolocation data and actively scan device characteristics for identification. This is done to store and access ...

Guidance on the use of capecitabine and tegafur with uracil for metastatic colorectal cancer TA61 27 May 2003 27 May 2003 Guidance on the use of drugs for early thrombolysis in the treatment of acute ...